Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

Artificial intelligence (AI) is transforming the health care landscape, from diagnostics to drug development and clinical trials. As AI ...

The FDA’s guidance on AI in drug development points to potentially life-threatening consequences of the technology, highlighting the importance of providing the regulator with detailed information ...

The FDA has responded to the increasing use of artificial intelligence (AI) in the discovery and development of drugs and ...

FDA introduces guidelines for lead levels in processed baby foods, aiming to enhance infant safety and reduce exposure to ...

Eli Lilly and Company has invested more than $20 billion in its manufacturing capabilities since 2020 to help meet high ...

Geewananda Gunawardana Ph.D. It is a relief to see that some actions are being taken to safeguard the nation’s medicinal ...

The science has proven that gene therapies are effective treatments, and they have given hope to patients and their families ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

The blood-brain barrier (BBB) is a major hurdle for the development of systemically delivered drugs targeting diseases of the central nervous system (CNS). Because of this barrier there is a huge ...

FP008 is a proprietary and patented drug candidate using Fapon Biopharma's cutting-edge antibody technology. As a first-in-class biologic, FP008 uniquely combines an engineered IL-10 monomer (IL-10M) ...